Library search

Here We Go Again: Has the European Court of Justice revived the cross-border patent injunction?

Intellectual Property Healthcare

After a brief period of inactivity, the European Court of Justice has revisited the subject of pan-European cross-border injunctions. In Solvay SA v. Honeywell Fluorine Products Europe BV and Others,...Read more

Paul Coletti

Associate Patent Counsel, Johnson & Johnson, USA

Canadian Risky Business: Why Fair and Predictable Patentable Utility is Critical to Investments and Innovation

Intellectual Property Pharmaceutical

Investment in innovation and procurement of patent protection within any jurisdiction is justified by reliance upon fair and predictable patent protection. For new investment within any particular jurisdiction, innovators expect...Read more